European Union -
English -
EMA (European Medicines Agency)
firazyr
takeda pharmaceuticals international ag - icatibant - angioedemas, hereditary - cardiac therapy - firazyr is indicated for symptomatic treatment of acute attacks of hereditary angioedema (hae) in adults (with c1-esterase-inhibitor deficiency).
Sweden -
English -
Läkemedelsverket (Medical Products Agency)
icatibant teva 30 mg injektionsvätska, lösning i förfylld spruta
Japan -
English -
すりの適正使用協議会 RAD-AR Council, Japan
firazyr subcutaneous injection 30mg syringe (フィラジル皮下注30mgシリンジ)
takeda pharmaceutical company limited. - icatibant acetate - injection
Malta -
English -
Medicines Authority
icatibant newbury 30 mg solution for injection in pre-filled syringe
newbury pharmaceuticals ab medicon village scheeletorget 1 223 81 lund, sweden - solution for injection in a pre-filled syringe - icatibant 30 mg - other hematological agents
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
icatibant gp pharm 30 mg injektionslösung in einer fertigspritze
Denmark -
English -
Lægemiddelstyrelsen (Danish Medicines Agency)
icatibant "sun" 30 mg injektionsvæske, opløsning i fyldt injektionssprøjte
Denmark -
English -
Lægemiddelstyrelsen (Danish Medicines Agency)
icatibant "adalvo" 30 mg injektionsvæske, opløsning i fyldt injektionssprøjte
Denmark -
English -
Lægemiddelstyrelsen (Danish Medicines Agency)
icatibant "stada arzneimittel ag" 30 mg injektionsvæske, opløsning i fyldt injektionssprøjte
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
icatibant beta 30 mg/3 ml injektionslösung in einer fertigspritze
Germany -
English -
BfArM (Bundesinstitut für Arzneimittel und Medizinprodukte)
icatibant aguettant 30 mg injektionslösung in einer fertigspritze